StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
CURXCuranex Pharmaceuticals Inc
stockpulse.co.kr
Nasdaq
$4.64▼ 3.53%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $131.6MShares out 28.4M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

5
  • 5d agoAfter-hours26.10.20 06:16
    S-8Offering#●●●#●●●

    Curanex Pharmaceuticals Inc

    Curanex Pharmaceuticals has registered the remaining 135,000 shares of its common stock to be issued under the 2026 Equity Incentive Plan. This registration is intended for employee equity compensation, following the company's 1-for-20 reverse stock split effected on August 20, 2026.…more

    $4.64-3.53%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 5d agoAfter-hours26.10.20 06:15
    8-KKey event

    Curanex Pharmaceuticals Inc

    Curanex Pharmaceuticals is facing two putative securities class actions alleging material misstatements and omissions in its August 2025 IPO offering documents. Plaintiffs claim damages related to risks of stock-price manipulation and deficiencies in underwriter due diligence, and the company intends to defend itself vigorously.…more

    $4.64-3.53%vs prev close
    View filingShare
  • 9.4After-hours26.09.05 05:15
    8-KKey event

    Curanex Pharmaceuticals Inc

    Curanex Pharmaceuticals has regained compliance with the Nasdaq minimum bid price requirement following a 1-for-20 reverse stock split effective August 20, 2026. The company maintained a closing bid price of $1.00 or greater for 10 consecutive business days from August 20 to September 2, 2026, officially closing the compliance matter.…more

    $4.64-3.53%vs prev close
    View filingShare

4 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 8.20Pre-market26.08.20 21:55

    Curanex Pharmaceuticals Trading Halt and Resumption

    Trading of Curanex Pharmaceuticals shares was temporarily halted and subsequently resumed. This notice reflects standard market procedures and does not contain specific positive or negative corporate news.…more

    $4.64-3.53%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 8.19After-hours26.08.20 08:50

    ●●●●●●●● ●●●●● ●●●●●●

    Trading of Curanex Pharmaceuticals stock has been halted pending the release of material news. Investors should monitor upcoming announcements as they may impact the stock price significantly.…more

    $4.64-3.53%vs prev close
    ShareBenzinga

1 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →